# Risk: __Lack of COVID-19 vaccine__ (PBN__Risk_2303)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskTechnology

* [vaccine development and manufacturing](../Technology/PBN__Technology_1885)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)

## Property: has_RiskType

* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskISO_Purpose

* [Resilience](../RiskISO/PBN__RiskISO_Impact_2)

## Property: has_RiskOwner

* [government](../Stakeholder/PBN__Stakeholder_73)
* [pharmaceutical companies](../Stakeholder/PBN__Stakeholder_124)

## Property: has_RiskMitigation

* [Development and distribution of an effective vaccine](../RiskMitigation/PBN__RiskMitigation_2992)

## Property: has_RiskName

Continued transmission of the virus, high number of infections and deaths

## Property: has_RiskDescription

The absence of a vaccine against COVID-19

## Property: has_RiskSource

* [walker_impact_2020](../Article/PBN__Article_65)

## Property: has_RiskGBN

* [No](../RiskGBN/PBN__RiskGBN_0)

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

